Sale!

MECP2 Gene Encephalopathy Neonatal Severe Genetic Test

Original price was: $700.Current price is: $500.

-29%

The MECP2 Gene Encephalopathy Neonatal Severe NGS Genetic DNA Test is a specialized genetic diagnostic tool that identifies mutations in the MECP2 gene associated with severe neonatal encephalopathy. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that cause devastating neurological conditions in newborns. Early diagnosis through this $500 USD test enables timely intervention, appropriate medical management, and informed family planning decisions. The test is particularly crucial for infants presenting with severe neurological symptoms, developmental delays, and respiratory abnormalities during the neonatal period.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

MECP2 Gene Encephalopathy Neonatal Severe NGS Genetic DNA Test

Comprehensive Introduction to MECP2 Gene Testing

The MECP2 Gene Encephalopathy Neonatal Severe NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations in the MECP2 gene that cause severe neonatal encephalopathy. This condition manifests as a devastating neurological disorder affecting newborns, characterized by profound developmental delays, respiratory complications, and severe neurological impairment. Early detection through this advanced genetic testing is crucial for implementing appropriate medical interventions and providing families with accurate prognostic information.

What This Test Measures and Detects

This sophisticated genetic analysis utilizes Next-Generation Sequencing (NGS) technology to comprehensively examine the MECP2 gene for pathogenic variants. The test specifically identifies:

  • Point mutations and small insertions/deletions in the MECP2 gene
  • Genetic variations associated with severe neonatal encephalopathy
  • Mutations linked to Rett syndrome spectrum disorders
  • Pathogenic variants causing early-onset neurological deterioration
  • Genetic markers for progressive encephalopathy in infancy

Who Should Consider This Genetic Test

This test is recommended for newborns and infants presenting with specific clinical symptoms indicative of MECP2-related disorders:

  • Infants with severe neonatal encephalopathy of unknown etiology
  • Newborns exhibiting developmental regression or stagnation
  • Babies with abnormal breathing patterns or respiratory complications
  • Infants showing hand-wringing movements or stereotypic hand movements
  • Children with microcephaly or decelerated head growth
  • Patients with seizures or abnormal EEG patterns
  • Infants with feeding difficulties and gastrointestinal issues
  • Cases with family history of neurological disorders or genetic conditions

Significant Benefits of MECP2 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages for patients and families:

  • Early and Accurate Diagnosis: Enables precise identification of the underlying genetic cause
  • Personalized Treatment Planning: Guides development of targeted therapeutic interventions
  • Prognostic Information: Provides valuable insights into disease progression and outcomes
  • Genetic Counseling Support: Facilitates informed family planning decisions
  • Clinical Management Guidance: Assists healthcare providers in optimizing patient care
  • Research Contribution: Advances understanding of neurological genetic disorders

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret and understand your test results:

  • Positive Result: Indicates the presence of a pathogenic MECP2 mutation, confirming the diagnosis of MECP2-related encephalopathy
  • Negative Result: Suggests no detectable MECP2 mutation, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if parents carry MECP2 mutations that could affect future pregnancies

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.

Schedule Your Genetic Test Today

Take the first step toward understanding your genetic health. Our experienced genetic counselors and neurological specialists are ready to assist you through every step of the testing process. Contact us now to schedule your appointment and begin your journey toward accurate diagnosis and personalized care.

Call or WhatsApp: +1(267) 388-9828

Our dedicated team understands the urgency and sensitivity surrounding neurological genetic testing. We provide compassionate care while delivering the highest quality genetic analysis using cutting-edge NGS technology. Don’t wait to get the answers you need for better health outcomes.